Hit tumors* hard with TheraSphere
TheraSphere is a targeted, FDA-approved radioembolization therapy. It consists of millions of glass microspheres containing radioactive Yttrium-90 (Y-90). TheraSphere allows for personalized and flexible dosing by offering both standard and custom vial options.
The evidence is in. 100% tumor response.¹
TheraSphere is the only Y-90 treatment assessed in over 100 clinical studies globally, confirming its effectiveness and impact on liver tumor response.